Roche Holding AG (RHHBF)
OTCMKTS · Delayed Price · Currency is USD
383.00
+3.00 (0.79%)
Oct 9, 2025, 12:20 PM EDT
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $312.59 billion as of October 9, 2025. Its market cap has increased by 22.66% in one year.
Market Cap
312.59B
Enterprise Value
346.05B
Revenue
79.83B
Ranking
n/a
PE Ratio
26.37
Stock Price
$383.00
Market Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 312.59B, an increase of 3,468.91%. That is a compound annual growth rate of 11.16%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 9, 2025 | 312.59B | 38.18% |
Dec 30, 2024 | 226.23B | -3.34% |
Dec 29, 2023 | 234.04B | -9.76% |
Dec 30, 2022 | 259.35B | -22.73% |
Dec 30, 2021 | 335.62B | 12.23% |
Dec 30, 2020 | 299.05B | 8.13% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Elite Pharmaceuticals | 683.67M |
Glass House Brands | 645.74M |
Veradigm | 528.17M |
Northwest Biotherapeutics | 379.57M |
Nika Pharmaceuticals | 333.67M |
CytoDyn | 314.22M |
American Oncology Network | 274.14M |
Silence Therapeutics | 242.78M |